Effect group in full replicate Bioequivalence [Study Per­for­mance]

posted by dshah  – India/United Kingdom, 2022-05-12 13:46 (270 d 18:15 ago) – Posting: # 22973
Views: 567

Hello Laura!
Generally fully replicate study will be useful for HVD or NTI. In both the condition, the Swt and Swr will play a role in BE acceptance (Particularly AUC). Assuming this- it is better to group according to date of administration of all periods.
Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
22,481 posts in 4,710 threads, 1,603 registered users;
27 visitors (0 registered, 27 guests [including 10 identified bots]).
Forum time: 07:02 CET (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5